Benign Prostatic Hyperplasia (BPH) Surgical Treatment Market to Reach USD 17.19 Billion by 2030 Amid Rising Demand for Minimally Invasive Procedures
The global benign prostatic hyperplasia (BPH) surgical treatment market is experiencing steady growth, driven by the increasing prevalence of prostate enlargement among aging men, advancements in minimally invasive treatment technologies, and rising awareness of effective BPH management. Valued at USD 11.92 billion in 2023, the market reached USD 12.62 billion in 2024 and is projected to grow at a...
Covid -19 Impact On The Benign Prostatic Hyperplasia Treatment Market
The report “Benign Prostatic Hyperplasia Treatment Market by Type [Drug (Alpha Blockers(Tamsulosin, Doxazosin), 5-Alpha Reductase Inhibitors (Finasteride, Dutasteride), Surgical Treatment (TURP, TUMT, TUNA], End User (Hospitals) – Global Forecast to 2026″ The Global Benign Prostatic Hyperplasia Treatment Market is projected to reach USD 14.1 billion by 2026 from USD...